FDA Removes Key Peptides from Category 2: What This Means for You BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York